Page-3 of Covishield

IndRa: Cost of vaccinating India’s population above 18 years 0.36% of GDP

The India Ratings and Research (Ind-Ra) recently said the estimated cost to vaccinate all the Indians of age 18 years will be Rs 67,193 crores. This is 0.36% of the GDP of the country. Key Findings The GoI recently announced ..

Month: 

COVAXIN: Transfer of Technology from Bharat Biotech to Haffkine

The Government of India recently approved the transfer of technology from Bharat Biotech to Hafkine Institute. COVAXIN COVAXIN is one of the two drugs that is currently administered in India. It is manufactured by Bharat Biotech in collaboration with the ..

Month: 

Why is GoI fast tracking the Emergency use of foreign made COVID-19 Vaccines?

The Government of India recently announced that it is speeding up the Emergency Usage Approvals of foreign made COVID-19 vaccines. This includes COVID-19 vaccines that have been granted Emergency Use Authorisation (EUA) in other countries. Role of NEGVAC in the ..

Month: 

India: Expert panel recommends approval to Sputnik V vaccine

An Expert panel of the Central Drugs Standard Control Organisation (CDSCO) recently approved the Emergency Use of COVID-19 vaccine Sputnik-V. However, the Drugs Controller General of India (DGCI) is to take a final call on the recommendation. When approved, Sputnik ..

Month: 

Tika Utsav: COVID-19 Vaccination Drive

The Prime Minister Narendra Modi recently appealed to the Chief Ministers of the States to organise “Tika Utsav”. What is Tika Utsav? Tika Utsav is a vaccine festival. It is to be held between April 11, 2021 and April 14, ..

Month: 

India-Seychelles High level Virtual Event

The Prime Minister Narendra Modi recently held a high-level programme with the President of Seychelles. The Prime Minister presented several gifts to Seychelles during the meet. Key Highlights of the Event During the meet, the two leaders jointly inaugurated the ..

Month: